619 results on '"Warren, Edus H."'
Search Results
2. Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer
3. Geographic EBV variants confound disease-specific variant interpretation and predict variable immune therapy responses
4. Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma
5. Therapeutic targeting of tumor spheroids in a 3D microphysiological renal cell carcinoma-on-a-chip system
6. Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas
7. Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphoma
8. Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL
9. CD4 and CD8 co-receptors modulate functional avidity of CD1b-restricted T cells
10. Signaling crosstalk between tumor endothelial cells and immune cells in the microenvironment of solid tumors
11. Immunohistochemical Detection of 5T4 in Renal Cell Carcinoma
12. Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study
13. Impact of Double- or Triple-Hit Pathology on Rates and Durability of Radiation Therapy Response Among Patients With Relapsed or Refractory Large B-Cell Lymphoma
14. Acalabrutinib in Combination with Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory B-Cell Lymphoma: A Phase I/II Study of Safety, Efficacy and Immune Correlative Analysis
15. Outcomes of Patients With Therapy-Related MDS After Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared With Patients With De Novo MDS: A Single-Institution Experience
16. Single cell atlas of kidney cancer endothelial cells reveals distinct expression profiles and phenotypes
17. Capacity building for hematologic malignancies in Uganda: a comprehensive research, training, and care program through the Uganda Cancer Institute–Fred Hutchinson Cancer Research Center collaboration
18. Preclinical development of T-cell receptor-engineered T-cell therapy targeting the 5T4 tumor antigen on renal cell carcinoma
19. An Antigen Produced by Splicing of Noncontiguous Peptides in the Reverse Order
20. High-Throughput Drug Screening and Multi-Omic Analysis to Guide Individualized Treatment for Multiple Myeloma
21. Clinical Determinants of Durable Clinical Benefit of Pembrolizumab in Veterans With Advanced Non–Small-Cell Lung Cancer
22. Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation
23. High-throughput sequencing of the B-cell receptor in African Burkitt lymphoma reveals clues to pathogenesis
24. Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease
25. CD8+ Minor Histocompatibility Antigen-Specific Cytotoxic T Lymphocyte Clones Eliminate Human Acute Myeloid Leukemia Stem Cells
26. Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer
27. Replication of associations between genetic polymorphisms and chronic graft-versus-host disease
28. Genetic risk factors for sclerotic graft-versus-host disease
29. Ultradeep, targeted sequencing reveals distinct mutations in blood compared to matched bone marrow among patients with multiple myeloma
30. CCR Translation for the Article from Development of Tumor-Reactive T Cells After Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant for Chronic Lymphocytic Leukemia
31. CCR Translation on this Article from C19orf48 Encodes a Minor Histocompatibility Antigen Recognized by CD8+ Cytotoxic T Cells from Renal Cell Carcinoma Patients
32. Supplementary Figures S1-S2 from C19orf48 Encodes a Minor Histocompatibility Antigen Recognized by CD8+ Cytotoxic T Cells from Renal Cell Carcinoma Patients
33. Supplementary Materials, Figures and Tables from A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure
34. Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans
35. Polatuzumab vedotin with infusional chemotherapy (Pola-DA-EPCH-R) for untreated aggressive B-cell non-Hodgkin lymphomas
36. The Impact of B-Cell-Directed Therapy on Sars-Cov-2 Vaccine Efficacy in CLL: 1-Year Follow up
37. Clinical Outcome and Treatment-Related Mortality in Patients with Acute Myeloid Leukemia Treated at the Uganda Cancer Institute
38. Circulating Tumor DNA in Untreated Classical Hodgkin Lymphoma Patients Treated with Pembrolizumab and Chemotherapy: Dynamic Response Assessment and Correlation with Baseline Metabolic Tumor Volume
39. T057: Circulating tumor DNA in classical Hodgkin lymphoma patients treated with pembrolizumab and chemotherapy: dynamic response assessment and correlation with baseline total metabolic tumor volume
40. Tracking the fate and origin of clinically relevant adoptively transferred CD8+ T cells in vivo
41. Integrated TCR repertoire analysis and single-cell transcriptomic profiling of tumor-infiltrating T cells in renal cell carcinoma identifies shared and tumor-restricted expanded clones with unique phenotypes
42. Case report: A persistently expanded T cell response in an exceptional responder to radiation and atezolizumab for metastatic non-small cell lung cancer
43. A prospective study of clinical outcomes of HIV-associated and HIV-negative Kaposi sarcoma in Uganda
44. Toward eliminating HLA class I expression to generate universal cells from allogeneic donors
45. High-throughput sequencing of B- and T-lymphocyte antigen receptors in hematology
46. Adoptive Immunotherapy of Human Diseases with Antigen-Specific T-Cell Clones
47. Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT
48. Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen
49. Evaluation of published single nucleotide polymorphisms associated with acute GVHD
50. Applications of Next-Generation Sequencing to Blood and Marrow Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.